Clinical stage company driving progress in healthy aging

Prof. Jay S. Siegel is an internationally recognized chemist whose work bridges the U.S., Switzerland, and China. He earned his PhD at Princeton, followed by postdoctoral work in Strasbourg and at ETH Zurich, before joining faculty at UC San Diego and later Zürich. In 2013, he moved to China to become Dean of the School of Pharmaceutical Science & Technology at Tianjin University. Currently he is Professor and Vice President Teaching and Learning at the University of Hong Kong.

His research focuses on molecular design, chemical synthesis, and structural analysis, especially in the realms of supramolecular architectures and stereochemistry.

Prof. Roger Schibli is Full Professor of Radiopharmaceutical Chemistry at ETH Zurich and Head of the Center for Radiopharmaceutical Sciences. He studied chemistry at the University of Basel and earned his PhD at the Paul Scherrer Institute. After a postdoctoral stay at the University of Missouri-Columbia, he joined ETH as Assistant Professor in 2004 and became Full Professor in 2019.

His research focuses on the design, chemical modification, and biological optimization of radiolabeled molecules for targeted tumor diagnosis and therapy, with particular emphasis on PET, SPECT, and theragnostic applications.

Prof. Oliver Distler is Professor of Rheumatology and Head of the Department of Rheumatology at University Hospital Zurich. He also leads the Center for Experimental Rheumatology at the University of Zurich, where he directs translational and clinical research into systemic sclerosis and fibrotic diseases.

His work ranges from uncovering molecular and cellular mechanisms of fibrosis, including the role of non-coding RNAs and biomarkers, to designing and conducting proof-of-concept and Phase 2/3 clinical trials. He has held visiting professorships at Stanford, Gothenburg, and Florence, and plays leading roles in international rheumatology and scleroderma networks such as FOREUM and EUSTAR.

Prof. Hyungil Jung is Professor of Biotechnology at Yonsei University, South Korea, where he is also affiliated with the Global Leaders College. He received his PhD in Environmental and Biological Engineering from Cornell University in 2002 and completed both an MS in Food and Biotechnology and a BA in Food Engineering at Yonsei University.

His research focuses on transdermal drug delivery, microneedle technologies, and related biomaterials and pharmaceutics. At Yonsei, he leads a research group dedicated to the development of advanced delivery systems.

Prof. Marie-Élise Truchetet is Professor of Rheumatology at the University of Bordeaux and a practicing rheumatologist at CHU Bordeaux, within the Pellegrin hospital group. She is also a member of the ImmunoConcept research unit, where her team focuses on systemic sclerosis and other autoimmune and inflammatory diseases.
She has published widely in the field of systemic sclerosis and contributes to the development of new therapeutic strategies. In recognition of her expertise, she was elected President of EUSTAR (European Scleroderma Trials and Research group) in 2025, where she plays a leading role in coordinating European research efforts on scleroderma.

Prof. Yannick Allanore is Professor of Rheumatology at Université Paris Cité and a practicing physician at Cochin Hospital in Paris. After a postdoctoral fellowship at Necker Hospital, he established his own research group at the Cochin Institute in 2011 through the ATIP-Avenir program.

His research focuses on systemic sclerosis and chronic fibro-inflammatory diseases, combining genetic approaches, animal models, and biobanks to identify new therapeutic targets and biomarkers. Since 2022, he has also served as Deputy Director of the Cochin Institute and plays a leading role in European research networks on systemic sclerosis (EUSTAR).

Prof. Sabine Werner is Full Professor of Cell Biology at ETH Zürich, where she has led the Molecular Health Sciences group since 1999. She studied biochemistry in Tübingen and Munich, completed her PhD at the Max Planck Institute for Biochemistry, and worked in Munich and San Francisco before joining ETH.

Her research focuses on the molecular mechanisms of tissue repair and wound healing, with a special interest in their links to cancer and chronic inflammation. She has received several prestigious awards and is a member of the Leopoldina, EMBO, and the European Academy of Sciences.